LESLIE REYNOLDS: Open Payments
NPI 1265045652 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 19 payments from 17 companies in 2025. Trend: 2023 $630 · 2024 $412 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $115 |
| Phathom Pharmaceuticals, Inc. | 1 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $104 |
| Amgen Inc. | 1 | $93 |
| Novo Nordisk Inc | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| Exact Sciences Corporation | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: AMVUTTRA, VOQUEZNA, Kerendia, REPATHA, Rybelsus, INGREZZA, Cologuard Collection Kit, UZEDY.
Industry payments across CA — which companies pay providers there.
